Back to Search
Start Over
Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.
- Source :
- Journal of Clinical Endocrinology & Metabolism; Jan2021, Vol. 106 Issue 1, pe350-e364, 15p
- Publication Year :
- 2021
-
Abstract
- <bold>Purpose: </bold>This work aimed to evaluate genotype-phenotype associations in individuals carrying germline variants of transmembrane protein 127 gene (TMEM127), a poorly known gene that confers susceptibility to pheochromocytoma (PHEO) and paraganglioma (PGL).<bold>Design: </bold>Data were collected from a registry of probands with TMEM127 variants, published reports, and public databases.<bold>Main Outcome Analysis: </bold>Clinical, genetic, and functional associations were determined.<bold>Results: </bold>The cohort comprised 110 index patients (111 variants) with a mean age of 45 years (range, 21-84 years). Females were predominant (76 vs 34, P < .001). Most patients had PHEO (n = 94; 85.5%), although PGL (n = 10; 9%) and renal cell carcinoma (RCC, n = 6; 5.4%) were also detected, either alone or in combination with PHEO. One-third of the cases had multiple tumors, and known family history was reported in 15.4%. Metastatic PHEO/PGL was rare (2.8%). Epinephrine alone, or combined with norepinephrine, accounted for 82% of the catecholamine profiles of PHEO/PGLs. Most variants (n = 63) occurred only once and 13 were recurrent (2-12 times). Although nontruncating variants were less frequent than truncating changes overall, they were predominant in non-PHEO clinical presentations (36% PHEO-only vs 69% other, P < .001) and clustered disproportionately within transmembrane regions (P < .01), underscoring the relevance of these domains for TMEM127 function. Integration of clinical and previous experimental data supported classification of variants into 4 groups based on mutation type, localization, and predicted disruption.<bold>Conclusions: </bold>Patients with TMEM127 variants often resemble sporadic nonmetastatic PHEOs. PGL and RCC may also co-occur, although their causal link requires further evaluation. We propose a new classification to predict variant pathogenicity and assist with carrier surveillance. [ABSTRACT FROM AUTHOR]
- Subjects :
- PHEOCHROMOCYTOMA
MULTIPLE tumors
GERM cells
RENAL cell carcinoma
MEMBRANE proteins
DATABASES
RESEARCH
GENETIC mutation
RESEARCH methodology
RETROSPECTIVE studies
GENETIC testing
MEDICAL cooperation
EVALUATION research
COMPARATIVE studies
DISEASE susceptibility
RESEARCH funding
ADRENAL tumors
GENETIC techniques
LONGITUDINAL method
Subjects
Details
- Language :
- English
- ISSN :
- 0021972X
- Volume :
- 106
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Journal of Clinical Endocrinology & Metabolism
- Publication Type :
- Academic Journal
- Accession number :
- 147866908
- Full Text :
- https://doi.org/10.1210/clinem/dgaa741